Bevacizumab vedotin
Product Sizes
1 mg
£ POA
HY-185208-1MG
5 mg
£ POA
HY-185208-5MG
10 mg
£ POA
HY-185208-10MG
About this Product
- SKU:
- HY-185208
- Extra Details:
- Bevacizumab vedotin is an antibody-drug conjugate (ADC). Bevacizumab vedotin blocks the VEGF/VEGFR pathway to exert anti-angiogenic effects. Bevacizumab vedotin exhibits anti-proliferative effects on cancer cells; promotes cancer cell apoptosis (Apoptosis); induces cancer cell cycle arrest; and possesses anti-migratory activity against breast cancer cells. Bevacizumab vedotin can be used in research related to glioma; hepatocellular carcinoma; and breast cancer[1].
- Molecular Weight:
- 149114 (average)
- Purity:
- 97.72
- Research Area:
- Cancer
- Shipping Conditions:
- Dry Ice
- Storage Conditions:
- -80[o]C; protect from light
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
